All In Biotech

Drug Trial Radar · NCT01718236

Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Last checked: Nov 20, 2026Latest source record: Jul 26, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

500

Actual

Start

Sep 2012

Primary completion

Jan 2015

Study completion Jan 2015

Sponsor

Lead sponsor
Brno University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
St. Anne's University Hospital Brno, Czech Republic; University Hospital Olomouc; IGA - internal grant agency, Ministry of Health
First posted
Oct 31, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
Single (participant)
Primary purpose
Treatment
Who can join
Female only, from 14 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The project aims to introduce into clinical practice for Caesarean section conducted under general anesthesia with the rapid induction myorelaxation with rocuronium and the reversal of neuromuscular blockade by using sugammadex. The aim is to demonstrate at least the same efficiency and confirm the safety of the procedure for both mother and newborn compared with older procedure.

Conditions

  • Caesarean Section
  • Pregnancy

Interventions

  • Rocuronium + sugammadexDrug

    Administration of rocuronium 1 mg/kg, intubation at decrease in Single Twitch to 10% of baseline event. by the disappearance of visible spikes event. in the 60th seconds after administration of muscle relaxants. Anesthesia with sevoflurane according to the MAC, neuromuscular blockade TOF count at 1-2.At the end of operation at PTC 1-2 sugammadex 4 mg/kg, at the TOF count 1-2, sugammadex 2 mg/kg, in the case of failure to achieve these values the anesthesiologist will wait until the minimum value of PTC 1-2 will be achieved. In can not intubate can not ventilate, and the failure of the introduction of laryngeal masks sugammadex 16mg/kg, immediately following the discovery of this fact and wait for the recovery of muscle strength. Time to recovery is recorded.

  • Succinylcholine + NeostigmineDrug

    1mg/kg succinylcholine iodide, intubation after decrease in Single Twitch to 10% of baseline event. after the disappearance of visible fasciculation event. in the 60th seconds after administration of muscle relaxants. Anesthesia with sevoflurane according to the MAC, at the moment of 20-30% of the original value of Single Twitch rocuronium 0.3 mg / kg, maintaining TOF Count at 1-2.At the end of operation at TOF Count 1-2 atropine 0.01 mg/kg and neostigmine 0.03 mg/kg. If TOF not 1-2 wait.In can not intubate can not ventilate, wait for the spontaneous recovery. Time to recovery of muscle strength is recorded.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. time needed to tracheal intubationTime frame: 2 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Faculty Hospital Olomouc

    Olomouc, Olomouc Region, Czechia

  • Faculty hospital Brno

    Brno, South Moravian, Czechia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.